Trials / Completed
CompletedNCT04479488
Brazilian Registry for Clinical Presentation of Individuals With COVID-19 (SARS-Brazil)
Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,587 (actual)
- Sponsor
- Hospital Israelita Albert Einstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a registry-based cohort study of all adult patients (≥18 years) with confirmed or suspected SARS-CoV-2 infection. The main goal is to describe mortality incidence, demographic characteristics, coexisting conditions, treatments, outcomes among SARS-CoV2 infected patients. A secondary goal is to identify biological factors (OMICS - genomic, proteomic and metabolomics characterization) associated with severity conditions for these patients.
Detailed description
Registry on characteristics and outcomes of hospitalized and non-hospitalized SARS-CoV2 infected patients in Brazil.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hospital admission | Usual care. |
| OTHER | Non-hospitalization procedures | Usual care. |
Timeline
- Start date
- 2020-07-27
- Primary completion
- 2021-03-30
- Completion
- 2022-12-30
- First posted
- 2020-07-21
- Last updated
- 2023-03-09
Locations
14 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04479488. Inclusion in this directory is not an endorsement.